title: Association of Intraocular Pressure Changes With Right Ventricular Diameter and Brain Natriuretic Peptide in a Case of Pulmonary Arterial Hypertension.
abstract: OBJECTIVE
  To report a case of secondary pulmonary arterial hypertension (PAH) and the relationship of intraocular pressure (IOP) change with right ventricular diameter (RVD) and brain natriuretic peptide (BNP).
  
  
  METHODS
  Case report.
  
  
  METHODS
  A 22-year-old woman with dilated and congested conjunctival and episcleral veins was diagnosed with high IOP. She was previously diagnosed with Sjögren syndrome and suffered from secondary PAH.
  
  
  RESULTS
  The RVD and BNP level improved and the IOP decreased with routine treatment for PAH. During self-cessation of treatment for PAH, the RVD, BNP level, and IOP deteriorated. However, they improved after treatment was reinitiated.
  
  
  CONCLUSIONS
  There was a synchronizing change in the parameters representing high pulmonary arterial pressure and IOP during treatment of PAH.
authors.affiliation: Departments of *Ophthalmology †Advanced Medicine in Cardiopulmonary Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan.
authors.forename: Chiaki
authors.initials: C
authors.lastname: Sato
authors.forename: Hiroki
authors.initials: H
authors.lastname: Kaneko
authors.forename: Takahisa
authors.initials: T
authors.lastname: Kondo
authors.forename: Kei
authors.initials: K
authors.lastname: Takayama
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Yasuda
authors.forename: Hiroko
authors.initials: H
authors.lastname: Terasaki
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D062185:Atrial Pressure / Q000502:physiology; D003228:Conjunctiva / Q000098:blood supply; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006352:Heart Ventricles / Q000473:pathology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D007429:Intraocular Pressure / Q000187:drug effects / Q000502:physiology*; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D009798:Ocular Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D012590:Sclera / Q000098:blood supply; D012859:Sjogren's Syndrome / Q000150:complications / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000959:Antihypertensive Agents; D004232:Diuretics; D014665:Vasodilator Agents; D020097:Natriuretic Peptide, Brain